Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 23 02 2020
accepted: 02 05 2020
pubmed: 13 5 2020
medline: 20 8 2020
entrez: 13 5 2020
Statut: ppublish

Résumé

The purpose of this study is to determine the role of clinico-sonographic features of breast cellular fibroepithelial lesions (CFELs) diagnosed on core needle biopsy (CNB) in the differentiation between fibroadenoma (FA) and phyllodes. Results of consecutive women with a CNB showing CFEL from 2005 to 2010 were retrospectively reviewed. Clinical and sonographic findings were compared with surgical outcomes. Chi-square and Fisher's exact tests were used followed by a regression model for statistical analysis. A total of 131 women with 134 CFEL were included in the study; 89 (66%) were FAs and 45 (34%) were phyllodes (32 benign; 13 malignant). Significant predictors of increased risk of phyllodes tumor were patient age equal to or greater than 50 years (P = .021) and lesion size less than 2 cm at sonography (P = .043). No other imaging or clinical features were able to differentiate FA from phyllodes tumors. CFEL with a larger size in older women is associated with the surgical pathological result of phyllodes tumor and management should be tailored accordingly. Younger patients with small size nodules might be approached less aggressively, depending on a personalized discussion with the surgeons, taking into account the results obtained in this study.

Identifiants

pubmed: 32396665
doi: 10.1002/jso.25977
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-387

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Krings G, Bean GR, Chen YY. Fibroepithelial lesions; the WHO spectrum. Semin Diagn Pathol. 2017;34(5):438-452. https://doi.org/10.1053/j.semdp.2017.05.006
Chen WH, Cheng SP, Tzen CY, et al. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases. J Surg Oncol. 2005;91(3):185-194. https://doi.org/10.1002/jso.20334
Tan PH, Thike AA, Tan WJ, et al. Predicting clinical behavior of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol. 2012;65(1):69-76. https://doi.org/10.1136/jclinpath-2011-2000368
McKenna AM, Pintilie M, Youngson B, Done SJ. Quantification of the morphologic features of fibroepithelial tumors of the breast. Arch Pathol Lab Med. 2007;131:1568-1573.
Jacobs TW. Update on fibroepithelial lesions of the breast. Surg Pathol Clin. 2009;2:301-317. https://doi.org/10.1016/j.path.2009.02.006
Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimising preoperative diagnosis in phyllodes tumour of the breast. J Clin Pathol. 2016;59(5):454-459.
Resetkova E, Khazai L, Albarracin CT, Arribas E. Clinical and radiologic data and core needle biopsy findings should dictate management of cellular fibroepithelial tumors of the breast. Breast J. 2010;16(6):573-580. https://doi.org/10.1111/j.1524-4741.2010.01013
Jung J, Kang E, Chae SM, et al. Development of a management algorithm for the diagnosis of cellular fibroepithelial lesions from core needle biopsies. Int J Surg Pathol. 2018;26(8):684-692. https://doi.org/10.1177/1066896918775525
Yilmaz E, Sal S, Lebe B. Differentiation of phyllodes tumors versus fibroadenomas. Acta Radiol. 2002;43(1):34-39.
Bode MK, Rissanen T, Apaja-Sarkkinen M. Ultrasonography and core needle biopsy in the differential diagnosis of fibroadenoma and tumor phyllodes. Acta Radiol. 2007;48(7):708-713.
Gatta G, Iaselli F, Parlato V, Di Grezia G, Grassi R, Rotondo A. Differential diagnosis between fibroadenoma, giant fibroadenoma and phyllodes tumour: sonographic features and core needle biopsy. Radiol Med. 2011;116(6):905-918. https://doi.org/10.1007/s11547-011-0672-y
Wiratkapun C, Piyapan P, Lertsithichai P, Larbcharoensub N. Fibroadenoma versus phyllodes tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy. Diagn Interv Radiol. 2014;20(1):27-33. https://doi.org/10.5152/dir.2013.13133
Duman L, Gezer NS, Balcı P, et al. Differentiation between phyllodes tumors and fibroadenomas based on mammographic sonographic and MRI features. Breast Care (Basel). 2016;11(2):123-127.
Adamietz BR, Kahmann L, Fasching PA, et al. Differentiation between phyllodes tumor and fibroadenoma using real-time elastography. Ultraschall Med. 2011;32(Suppl 2):E75-E79. https://doi.org/10.1055/s-0031-1282024
Kim GR, Choi JS, Han BK, Ko EY, Ko ES, Hahn SY. Combination of shear-wave elastography and color Doppler: feasible method to avoid unnecessary breast excision of fibroepithelial lesions diagnosed by core needle biopsy. PLOS One. 2017;12(5):e0175380. https://doi.org/10.1371/journal.pone.0175380
American College of Radiology. ACR breast imaging reporting and data system: breast imaging atlas. Reston, VA: American College of Radiology; 2003.
Gordon PB, Gagnon FA, Lanzkowsky L. Solid breast masses diagnosed as fibroadenoma at fine-needle aspiration biopsy: acceptable rates of growth at long-term follow-up. Radiology. 2003;229(1):233-238. https://doi.org/10.1148/radiol.2291010282
Barth RJ, Wells WA, Mitchell SE, Cole BF. A prospective, multi-institutional study of adjuvant radiotherapy after resection of malignant phyllodes tumors. Ann Surg Oncol. 2009;16(8):2288-2294. https://doi.org/10.1245/s10434-009-0489-2
Chu B, Crystal P. Imaging of fibroepithelial lesions: a pictorial essay. Can Assoc Radiol J. 2012;63(2):135-145. https://doi.org/10.1016/j.carj.2010.08.004
Goel NB, Knight TE, Pandey S, Riddick-Young M, de Paredes ES, Trivedi A. Fibrous lesions of the breast: imaging-pathologic correlation. Radiographics. 2005;25(6):1547-1559. https://doi.org/10.1148/rg.256045183
Kalambo M, Adrada BE, Adeyefa MM, et al. Phyllodes tumor of the breast: ultrasound-pathology correlation. Am J Roentgenol. 2018;210(4):W173-W179. https://doi.org/10.2214/AJR.17.18554

Auteurs

Basma Al-Arnawoot (B)

Department of Diagnostic Imaging, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.

Anabel Scaranelo (A)

Joint Department of Medical Imaging, Mount Sinai Hospital, Women's College Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.

Rachel Fleming (R)

Joint Department of Medical Imaging, Mount Sinai Hospital, Women's College Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.

Supriya Kulkarni (S)

Joint Department of Medical Imaging, Mount Sinai Hospital, Women's College Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.

Ravi J Menezes (RJ)

Joint Department of Medical Imaging, Mount Sinai Hospital, Women's College Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.

David McCready (D)

Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

Susan Done (S)

Laboratory Medicine Program, University Health Network-Toronto General Hospital Site, University of Toronto, Toronto, Ontario, Canada.

Vivianne Freitas (V)

Joint Department of Medical Imaging, Mount Sinai Hospital, Women's College Hospital, University of Toronto, University Health Network, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH